Syndax Pharmaceuticals Stock Forecast - Naive Prediction
| SNDX Stock | USD 20.25 0.54 2.60% |
Syndax Stock outlook is based on your current time horizon.
At this time, The RSI of Syndax Pharmaceuticals' share price is at 55. This usually implies that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Syndax Pharmaceuticals, making its price go up or down. Momentum 55
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.58) | EPS Estimate Current Year (3.07) | EPS Estimate Next Year (1.60) | Wall Street Target Price 39.3077 | EPS Estimate Current Quarter (0.71) |
Using Syndax Pharmaceuticals hype-based prediction, you can estimate the value of Syndax Pharmaceuticals from the perspective of Syndax Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Syndax Pharmaceuticals using Syndax Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Syndax using crowd psychology based on the activity and movement of Syndax Pharmaceuticals' stock price.
Syndax Pharmaceuticals Short Interest
An investor who is long Syndax Pharmaceuticals may also wish to track short interest. As short interest increases, investors should be becoming more worried about Syndax Pharmaceuticals and may potentially protect profits, hedge Syndax Pharmaceuticals with its derivative instruments, or be ready for some potential downside.
200 Day MA 14.4443 | Short Percent 0.2929 | Short Ratio 14.53 | Shares Short Prior Month 22.8 M | 50 Day MA 19.8916 |
Syndax Relative Strength Index
The Naive Prediction forecasted value of Syndax Pharmaceuticals on the next trading day is expected to be 20.14 with a mean absolute deviation of 0.40 and the sum of the absolute errors of 24.68.Syndax Pharmaceuticals Hype to Price Pattern
Investor biases related to Syndax Pharmaceuticals' public news can be used to forecast risks associated with an investment in Syndax. The trend in average sentiment can be used to explain how an investor holding Syndax can time the market purely based on public headlines and social activities around Syndax Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Syndax Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Syndax Pharmaceuticals.
Syndax Pharmaceuticals Implied Volatility | 0.96 |
Syndax Pharmaceuticals' implied volatility exposes the market's sentiment of Syndax Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Syndax Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Syndax Pharmaceuticals stock will not fluctuate a lot when Syndax Pharmaceuticals' options are near their expiration.
The Naive Prediction forecasted value of Syndax Pharmaceuticals on the next trading day is expected to be 20.14 with a mean absolute deviation of 0.40 and the sum of the absolute errors of 24.68. Syndax Pharmaceuticals after-hype prediction price | USD 20.31 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Syndax Pharmaceuticals to cross-verify your projections. Prediction based on Rule 16 of the current Syndax contract
Based on the Rule 16, the options market is currently suggesting that Syndax Pharmaceuticals will have an average daily up or down price movement of about 0.06% per day over the life of the 2026-04-17 option contract. With Syndax Pharmaceuticals trading at USD 20.25, that is roughly USD 0.0122 . If you think that the market is fully incorporating Syndax Pharmaceuticals' daily price movement you should consider acquiring Syndax Pharmaceuticals options at the current volatility level of 0.96%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 Syndax Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Syndax Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Syndax Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Syndax Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Syndax Pharmaceuticals' open interest, investors have to compare it to Syndax Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Syndax Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Syndax. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Syndax Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Syndax price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Syndax using various technical indicators. When you analyze Syndax charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Syndax Pharmaceuticals' financial statements to predict how it will affect future prices.
Cash | First Reported 2012-12-31 | Previous Quarter 108.6 M | Current Value 116.8 M | Quarterly Volatility 62.3 M |
Syndax Pharmaceuticals Naive Prediction Price Forecast For the 27th of January
Given 90 days horizon, the Naive Prediction forecasted value of Syndax Pharmaceuticals on the next trading day is expected to be 20.14 with a mean absolute deviation of 0.40, mean absolute percentage error of 0.29, and the sum of the absolute errors of 24.68.Please note that although there have been many attempts to predict Syndax Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Syndax Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Syndax Pharmaceuticals Stock Forecast Pattern
| Backtest Syndax Pharmaceuticals | Syndax Pharmaceuticals Price Prediction | Buy or Sell Advice |
Syndax Pharmaceuticals Forecasted Value
In the context of forecasting Syndax Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Syndax Pharmaceuticals' downside and upside margins for the forecasting period are 16.41 and 23.87, respectively. We have considered Syndax Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Syndax Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Syndax Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 116.863 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.4046 |
| MAPE | Mean absolute percentage error | 0.0216 |
| SAE | Sum of the absolute errors | 24.6793 |
Predictive Modules for Syndax Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Syndax Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Syndax Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Syndax Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Syndax Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Syndax Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Syndax Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Syndax Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Syndax Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Syndax Pharmaceuticals' historical news coverage. Syndax Pharmaceuticals' after-hype downside and upside margins for the prediction period are 16.55 and 24.07, respectively. We have considered Syndax Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Syndax Pharmaceuticals is not too volatile at this time. Analysis and calculation of next after-hype price of Syndax Pharmaceuticals is based on 3 months time horizon.
Syndax Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Syndax Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Syndax Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Syndax Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.72 | 3.73 | 0.06 | 0.22 | 10 Events / Month | 7 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
20.25 | 20.31 | 0.30 |
|
Syndax Pharmaceuticals Hype Timeline
Syndax Pharmaceuticals is at this time traded for 20.25. The entity has historical hype elasticity of 0.06, and average elasticity to hype of competition of 0.22. Syndax is forecasted to increase in value after the next headline, with the price projected to jump to 20.31 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 0.3%, whereas the daily expected return is at this time at 0.72%. The volatility of related hype on Syndax Pharmaceuticals is about 1239.2%, with the expected price after the next announcement by competition of 20.47. The company reported the previous year's revenue of 23.68 M. Net Loss for the year was (318.76 M) with loss before overhead, payroll, taxes, and interest of (133.23 M). Given the investment horizon of 90 days the next forecasted press release will be in about 10 days. Check out Historical Fundamental Analysis of Syndax Pharmaceuticals to cross-verify your projections.Syndax Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Syndax Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Syndax Pharmaceuticals' future price movements. Getting to know how Syndax Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Syndax Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RLAY | Relay Therapeutics | 0.34 | 12 per month | 3.22 | 0.02 | 5.60 | (5.45) | 27.25 | |
| INBX | Inhibrx Biosciences | 0.48 | 9 per month | 4.20 | 0.11 | 7.03 | (6.08) | 112.80 | |
| AMLX | Amylyx Pharmaceuticals | 0.08 | 9 per month | 2.88 | 0.01 | 8.11 | (4.94) | 19.81 | |
| ORIC | Oric Pharmaceuticals | (0.07) | 9 per month | 3.06 | (0.02) | 6.63 | (4.36) | 15.34 | |
| NKTR | Nektar Therapeutics | 2.74 | 10 per month | 0.00 | (0.17) | 6.56 | (7.77) | 20.31 | |
| SANA | Sana Biotechnology | (0.15) | 7 per month | 0.00 | (0.02) | 12.59 | (8.77) | 25.63 | |
| IMTX | Immatics NV | 0.1 | 8 per month | 0.00 | (0.03) | 7.31 | (6.47) | 30.34 | |
| CVAC | CureVac NV | 0.05 | 7 per month | 0.00 | (0.11) | 3.33 | (2.80) | 18.10 | |
| ATAI | ATAI Life Sciences | (0.01) | 8 per month | 0.00 | (0.17) | 5.77 | (5.54) | 22.95 | |
| ZBIO | Zenas BioPharma Common | (0.55) | 10 per month | 11.22 | 0.01 | 13.19 | (8.49) | 84.91 |
Other Forecasting Options for Syndax Pharmaceuticals
For every potential investor in Syndax, whether a beginner or expert, Syndax Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Syndax Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Syndax. Basic forecasting techniques help filter out the noise by identifying Syndax Pharmaceuticals' price trends.Syndax Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Syndax Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Syndax Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Syndax Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Syndax Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Syndax Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Syndax Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Syndax Pharmaceuticals stock market strength indicators, traders can identify Syndax Pharmaceuticals entry and exit signals to maximize returns.
Syndax Pharmaceuticals Risk Indicators
The analysis of Syndax Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Syndax Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting syndax stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.77 | |||
| Semi Deviation | 2.36 | |||
| Standard Deviation | 3.84 | |||
| Variance | 14.77 | |||
| Downside Variance | 6.55 | |||
| Semi Variance | 5.57 | |||
| Expected Short fall | (3.72) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Syndax Pharmaceuticals
The number of cover stories for Syndax Pharmaceuticals depends on current market conditions and Syndax Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Syndax Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Syndax Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Syndax Pharmaceuticals Short Properties
Syndax Pharmaceuticals' future price predictability will typically decrease when Syndax Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Syndax Pharmaceuticals often depends not only on the future outlook of the potential Syndax Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Syndax Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 85.6 M | |
| Cash And Short Term Investments | 582.9 M |
Additional Tools for Syndax Stock Analysis
When running Syndax Pharmaceuticals' price analysis, check to measure Syndax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syndax Pharmaceuticals is operating at the current time. Most of Syndax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Syndax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syndax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Syndax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.